Cost-effectiveness analysis of Gatifloxacin and Levofloxacin in the treatment of patients with lower respiratory tract infection

OBJECTIVE To evaluate the cost-effectiveness of gatifloxacin and levofloxacin in the treatment of patients with lower respiratory tract infection,promote rational use of the drugs and decrease the treatment cost.METHODS The cost-effectiveness was analyzed with medical cost-effectiveness analyzing method gatifloxacin and levofloxacin were compared in the treatment of patients with lower respiratory tract infection based on the published reference data.RESULTS and CONCLUSION There is no obvious difference between these two drugs in clinical effective rate and cure rate of patients with lower respiratory tract infection,but the bacteria clearance ratio of gatifloxacin was superior to that of levofloxacin.Cost-effectiveness ratio of levofloxacin is superior to that of gatifloxacin.